Abstract
This observational cohort study aimed to examine the association between the duration of phototherapy for neonatal jaundice and the risk of developmental delay at 3 years of age using nationwide birth cohort data. Data from 76,897 infants were analyzed. We divided participants into four groups: no phototherapy, short phototherapy (1–24 h), long phototherapy (25–48 h), and very long phototherapy (> 48 h). The Japanese version of the Ages and Stages Questionnaire-3 was used to evaluate the risk of developmental delay at 3 years of age. Logistic regression analysis was performed to assess the impact of phototherapy duration on the prevalence of developmental delay. After adjustment for potential risk factors, a dose–response relationship was identified between the duration of phototherapy and Ages and Stages Questionnaire-3, and the differences were significant in four domains; odds ratio for communication delay was associated with short, long, and very long phototherapy = 1.10 (95% confidence interval 0.97–1.26), 1.32 (1.04–2.66), and 1.48 (1.11–1.98), respectively; for gross motor delay = 1.01 (0.89–1.15), 1.28 (1.03–2.58), and 1.26 (0.96–1.67); for problem solving delay = 1.13 (1.03–1.25), 1.19 (0.99–1.43), and 1.41 (1.11–1.79); and for personal social delay = 1.15 (0.99–1.32), 1.10 (0.84–1.44), and 1.84 (1.38–2.45).
Conclusion: Longer duration of phototherapy is a predictive factor for developmental delay, making it important to avoid extended periods of phototherapy. However, whether it increases the prevalence of developmental delay remains unclear.
What is Known: • Phototherapy is a common treatment for neonatal jaundice, associated with both short-term and long-term complications. • However, an association between phototherapy and the prevalence of developmental delay has not been revealed in a large cohort study. | |
What is New: • We identified that a long duration of phototherapy was a predictive factor for developmental delay at 3 years of age. • However, whether a long duration of phototherapy increases the prevalence of developmental delay remains unclear. |
Similar content being viewed by others
Data availability
Data are unsuitable for public deposition due to ethical restrictions and legal framework of Japan. It is prohibited by the Act on the Protection of Personal Information (Act No. 57 of 30 May 2003, amendment on 9 September 2015) to publicly deposit the data containing personal information. Ethical Guidelines for Medical and Health Research Involving Human Subjects enforced by the Japan Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare also restricts the open sharing of the epidemiologic data. All inquiries about access to data should be sent to: jecs-en@nies.go.jp. The person responsible for handling enquiries sent to this e-mail address is Dr Shoji F. Nakayama, JECS Programme Office, National Institute for Environmental Studies.
Change history
01 April 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00431-023-04942-0
Abbreviations
- ASQ-3:
-
The Ages and Stages Questionnaires third edition
- CI:
-
Confidence interval
- DNA:
-
Deoxyribonucleic acid
- IL:
-
Interleukin
- JECS:
-
Japan Environment and Children’s Study
- LED:
-
Light-emitting diode
- OR:
-
Odds ratio
- UV:
-
Ultraviolet
References
Le Pichon JB, Riordan SM, Watchko J, Shapiro SM (2017) The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr Pediatr Rev 13:199–209
Newman TB, Xiong B, Gonzales VM, Escobar GJ (2000) Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154:1140–1147
Drew JH, Marriage K, Bayle VV, Bajraszewski E, McNammara JM (1976) Phototherapy. Short and long-term complications. Arch Dis Child 51:454–458
Hotta M, Ueda K, Ikehara S, Tanigawa K, Nakayama H, Wada K, Kimura T, Ozono K, Sobue T, Iso H (2022) The duration of neonatal phototherapy and allergic disorders: the Japan Environment and Children’s Study. Int Arch Allergy Immunol:1–9
Ku MS (2018) Neonatal phototherapy: a novel therapy to prevent allergic skin disease for at least 5 years. Neonatology 114:235–241
Wei CC, Lin CL, Shen TC, Kao CH (2015) Neonatal jaundice and risks of childhood allergic diseases: a population-based cohort study. Pediatr Res 78:223–230
Wickremasinghe AC, Kuzniewicz MW, Grimes BA, McCulloch CE, Newman TB (2016) Neonatal phototherapy and infantile cancer. Pediatrics 137
Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, McDavid GE et al (2008) Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 359:1885–1896
Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ (1990) Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics 85:455–463
Kawamoto T, Nitta H, Murata K, Toda E, Tsukamoto N, Hasegawa M, Yamagata Z, Kayama F, Kishi R, Ohya Y, Saito H, Sago H, Okuyama M, Ogata T, Yokoya S, Koresawa Y, Shibata Y, Nakayama S, Michikawa T, Takeuchi A, Satoh H, Working Group of the Epidemiological Research for Children’s Environmental H (2014) Rationale and study design of the Japan environment and children’s study (JECS). BMC Public Health 14:25
Michikawa T, Nitta H, Nakayama SF, Yamazaki S, Isobe T, Tamura K, Suda E, Ono M, Yonemoto J, Iwai-Shimada M, Kobayashi Y, Suzuki G, Kawamoto T, Japan E, Children’s Study G (2018) Baseline profile of participants in the Japan Environment and Children’s Study (JECS). J Epidemiol 28:99–104
Squires J PL, Bricker D (2009) The ASQ-3TM User’s Guide. Brookes
Mezawa H, Aoki S, Nakayama SF, Nitta H, Ikeda N, Kato K, Tamai S, Takekoh M, Sanefuji M, Ohga S, Oda M, Mitsubuchi H, Senju A, Kusuhara K, Kuwajima M, Koeda T, Ohya Y, Hashimoto K (2019) Psychometric profile of the Ages and Stages Questionnaires, Japanese translation. Pediatr Int 61:1086–1095
Brown AK, Kim MH, Wu PY, Bryla DA (1985) Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75:393–400
Tyson JE, Parikh NA, Langer J, Green C, Higgins RD, National Institute of Child H, Human Development Neonatal Research N (2008) Intensive care for extreme prematurity–moving beyond gestational age. N Engl J Med 358:1672–1681
Kapitulnik J (2004) Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66:773–779
Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H (2010) Light, including ultraviolet. J Autoimmun 34:J247-257
Tatli MM, Minnet C, Kocyigit A, Karadag A (2008) Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 654:93–95
Kurt A, Aygun AD, Kurt AN, Godekmerdan A, Akarsu S, Yilmaz E (2009) Use of phototherapy for neonatal hyperbilirubinemia affects cytokine production and lymphocyte subsets. Neonatology 95:262–266
Procianoy RS, Silveira RC, Fonseca LT, Heidemann LA, Neto EC (2010) The influence of phototherapy on serum cytokine concentrations in newborn infants. Am J Perinatol 27:375–379
Manning D, Todd P, Maxwell M, Jane Platt M (2007) Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 92:F342-346
Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ, Ehrenkranz RA, Carlo WA, Shankaran S, Poole K, Wright LL, National Institute of Child H, Human Development Neonatal Research N (2003) Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 112:773–779
Arnold C, Pedroza C, Tyson JE (2014) Phototherapy in ELBW newborns: does it work? Is it safe? The evidence from randomized clinical trials. Semin Perinatol 38:452–464
Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, Maisels MJ, Lau J, American Academy of Pediatrics Subcommittee on H (2004) An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114:e130-153
Acknowledgements
We are grateful to all the JECS participants and all individuals involved in data collection. This study was funded by the Ministry of Environment, Japan. The findings and conclusions of this study are solely the responsibility of the authors and do not represent the official views of the Ministry of the Environment. Members of the JECS Group as of 2022: Michihiro Kamijima (principal investigator, Nagoya City University, Nagoya, Japan), Shin Yamazaki (National Institute for Environmental Studies, Tsukuba, Japan), Yukihiro Ohya (National Center for Child Health and Development, Tokyo, Japan), Reiko Kishi (Hokkaido University, Sapporo, Japan), Nobuo Yaegashi (Tohoku University, Sendai, Japan), Koichi Hashimoto (Fukushima Medical University, Fukushima, Japan), Chisato Mori (Chiba University, Chiba, Japan), Shuichi Ito (Yokohama City University, Yokohama, Japan), Zentaro Yamagata (University of Yamanashi, Chuo, Japan), Hidekuni Inadera (University of Toyama, Toyama, Japan), Takeo Nakayama (Kyoto University, Kyoto, Japan), Tomotaka Sobue (Osaka University, Suita, Japan), Masayuki Shima (Hyogo Medical University, Nishinomiya, Japan), Hiroshige Nakamura(Tottori University, Yonago, Japan), Narufumi Suganuma (Kochi University, Nankoku, Japan), Koichi Kusuhara (University of Occupational and Environmental Health, Kitakyushu, Japan), and Takahiko Katoh (Kumamoto University, Kumamoto, Japan).
Funding
This study was funded by the Ministry of the Environment, Japan. The Ministry of the Environment, Japan had no role in the design and conduct of the study. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the government.
Author information
Authors and Affiliations
Consortia
Contributions
Masashi Hotta conceptualized and designed the study, analyzed the data, drafted the initial manuscript, and reviewed and revised the manuscript. Kimiko Ueda, Satoyo Ikahara, Kanami Tanigawa, Hirofumi Nakayama, Kazuko Wada, Tadashi Kimura, Keiichi Ozono, Tomotaka Sobue, and Hiroyasu Iso contributed to the writing and revising of the manuscript. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics approval
The Japan Environment and Children’s Study protocol was reviewed and approved by the Ministry of the Environment’s Institutional Review Board for Epidemiological Studies and the Ethics Committees of all participating institutions (Ethical Number: No.100910001).
Consent to participate
Written informed consent was obtained from all the participants and their parent/legal guardian/next of kin to participate in the study.
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Daniele De Luca.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised due to missing row heading “Continuous variables, Mean (Standard deviation)” in last entry of Table 1, now added.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hotta, M., Ueda, K., Ikehara, S. et al. Phototherapy and risk of developmental delay: the Japan Environment and Children’s Study. Eur J Pediatr 182, 2139–2149 (2023). https://doi.org/10.1007/s00431-022-04785-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-022-04785-1